JN.1 most common COVID variant in US by Dec 23?
$3,923 Объем
$3,923 Объем
Dec 23, 2023
Правила
This market will resolve to "Yes" if the JN.1 variant of SARS-CoV-2 is responsible for the most COVID-19 cases by proportion in the United States according to CDC's Nowcast at the time of its next release (after 12/9/23). Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.
The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.
Создано: Dec 19, 2023, 12:57 PM ET
Объем
$3,923Дата окончания
Dec 23, 2023Создано
Dec 19, 2023, 12:57 PM ETResolution Source
https://covid.cdc.gov/covid-data-tracker/#variant-proportionsResolver
0x6A9D22261...Результат предложен: Yes
Нет спора
Финальный результат: Yes
JN.1 most common COVID variant in US by Dec 23?
$3,923 Объем
$3,923 Объем
Dec 23, 2023
О событии
This market will resolve to "Yes" if the JN.1 variant of SARS-CoV-2 is responsible for the most COVID-19 cases by proportion in the United States according to CDC's Nowcast at the time of its next release (after 12/9/23). Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.
The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.
Объем
$3,923Дата окончания
Dec 23, 2023Создано
Dec 19, 2023, 12:57 PM ETResolution Source
https://covid.cdc.gov/covid-data-tracker/#variant-proportionsResolver
0x6A9D22261...Результат предложен: Yes
Нет спора
Финальный результат: Yes
Остерегайтесь внешних ссылок.
Остерегайтесь внешних ссылок.

Остерегайтесь внешних ссылок.
Остерегайтесь внешних ссылок.